Expert testimony

Image for Expert testimony

Translational Science Benefits

Icon for Clinical & medical benefits


Icon for Community & public health benefits


Icon for Economic benefits


Icon for Policy & legislative benefits


Policy & legislative benefits (Advisory activities)


Formal presentation of data or results to governmental, judicial or other regulatory bodies. Examples include written or oral testimony before a legislative committee or a criminal or civil court case.


Presentation of research data or results in expert testimony is evidence of potential influence on the policy-making process.


Advice from authors on searching for information:

Self-reported documentation of researchers’ testimony can be helpful as full-text search is not available for all governmental, judicial, or other regulatory bodies. Documents available from state legislative bodies vary widely.

Resources & Data

Organizations, repositories, websites, and other sources where you can find more information:



  • provides access to accurate, timely and complete legislative information. It is usually updated the morning after a session adjourns.
  • ProQuest Congressional is a database with a comprehensive collection of current and historic Congressional information. There is a search by witness name and witness affiliation that can help identify expert testimony to Congress.

Data Limitations

Challenges you may encounter while searching for information:

Access to self-reported researcher or administrative/in-house data may be required to locate documentation.


Articles, books, and other publications in translational science using the indicator:

Case Studies

Safely Reopening Schools during COVID-19

By ICTS and UCI Institute for Clinical & Translational Science

Leveraging multidisciplinary collaboration and partnerships to create guidance for schools navigating the pandemic

Children in their classroom listening to their teacher

Disseminating Evidence about Adverse Childhood Experiences (ACEs)

By ICTS and Implementation Research Institute (IRI)

Communicating about ACEs and behavioral health to policymakers and the public

Using Prophylactic HIV Medicine to Reduce Infection Risk


Studying the uptake of PrEP in high-risk populations, leading to an expansion of services including a new clinic.